Related Experiment Video

Updated: Jun 4, 2026

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI

Amburanjan Santra1, Rakesh Kumar, Punit Sharma

  • 1Department of Nuclear Medicine, Medical College Kolkata, Kolkata, India. a_ranjan_santra@yahoo.co.in

European Journal of Radiology
|March 1, 2011
PubMed
Abstract

Insights

Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (FDG PET-CT) is highly specific for detecting recurrent gliomas, outperforming contrast-enhanced MRI. This imaging technique effectively differentiates tumor recurrence from post-therapy changes in glioma patients.

Area of Science:

  • Neuro-oncology
  • Medical imaging
  • Nuclear medicine

Background:

  • Gliomas are primary brain tumors with a high recurrence rate.
  • Accurate detection of recurrent gliomas is crucial for timely treatment adjustments.
  • Distinguishing tumor recurrence from post-therapy changes can be challenging with conventional imaging.

Purpose of the Study:

  • To compare the diagnostic efficacy of FDG PET-CT and contrast-enhanced MRI in detecting recurrent gliomas.
  • To evaluate the sensitivity, specificity, and accuracy of both imaging modalities.

Main Methods:

  • Ninety patients with histopathologically confirmed gliomas and suspected recurrence were included.
  • All patients underwent both FDG PET-CT and contrast-enhanced MRI.
  • Gold standard for recurrence confirmation included clinical follow-up, repeat imaging, and biopsy when available.

Main Results:

  • FDG PET-CT demonstrated higher specificity (97%) and accuracy (80%) compared to contrast-enhanced MRI (23% specificity, 70% accuracy).
  • MRI showed higher sensitivity (95%) than FDG PET-CT (70%), except in Grade II gliomas where sensitivities were comparable.
  • FDG PET-CT exhibited high specificity across all tumor grades (83-100%), while MRI showed very low specificity (18-33%).

Conclusions:

  • FDG PET-CT is a highly specific imaging modality for diagnosing recurrent gliomas.
  • FDG PET-CT can effectively differentiate tumor recurrence from post-therapy changes.
  • FDG PET-CT offers superior specificity in glioma recurrence detection compared to contrast-enhanced MRI.

More Related Videos

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury09:58

Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury

Published on: November 9, 2018

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET09:03

Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

Published on: October 22, 2019

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET